<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01041365</url>
  </required_header>
  <id_info>
    <org_study_id>F090824002</org_study_id>
    <nct_id>NCT01041365</nct_id>
  </id_info>
  <brief_title>Vitamin D, Insulin Sensitivity, and Vascular Associations in Adolescents</brief_title>
  <acronym>DIVA</acronym>
  <official_title>Serum 25-hydroxyvitamin D, Vascular Functioning, and Insulin Sensitivity in Adolescent Girls [The DIVA Study (Vitamin D, Insulin, and Vascular Associations)] (Pediatric Physician Training in Translational Research)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objectives of this study are to examine the relationships between circulating
      vitamin D, insulin sensitivity, and multiple indices of vascular function and to examine
      whether vitamin D deficiency in AA is responsible for ethnic differences in insulin
      sensitivity and hypertension in AA and EA, as well as mechanisms underlying the association
      between insulin resistance and blood pressure. We hypothesize that 1) serum 25(OH)D is
      associated with insulin sensitivity and vascular functioning, independent of adiposity, 2)
      lower insulin sensitivity and vascular functioning in AA relative to EA is due to lower
      circulating 25(OH)D in AA, and 3) the relationship between insulin resistance and vascular
      dysfunction is mediated by 25(OH)D.

      Acronyms: African American (AA), European American (EA), Serum 25-hydroxy vitamin D (25()H)D,
      Body mass index (BMI), Alabama (AL).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>Cross sectional study: at the first study visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vascular Function</measure>
    <time_frame>Cross sectional study: at the second study visit, within 2 weeks of first study visit</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">62</enrollment>
  <condition>Insulin Sensitivity</condition>
  <condition>Flow-mediated Dilation</condition>
  <condition>Arterial Stiffness</condition>
  <arm_group>
    <arm_group_label>Healthy adolescents</arm_group_label>
    <description>Healthy adolescent African American and Caucasian females, ages 14-18</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy adolescent African American and European American teenagers, ages 14-18, will be
        recruited form the Birmingham, AL community
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  African American or Caucasian ethnicity

          -  Ages 14-18 yrs

          -  Healthy

        Exclusion Criteria:

          -  BMI-for age and -sex higher than 95th centile on the Centers for Disease Control and
             Prevention Growth Charts

          -  Use of medication(s) known to influence body composition, vascular function, or
             glucose metabolism

          -  Pregnancy

          -  Diabetes or any chronic diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ambika Ashraf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2009</study_first_submitted>
  <study_first_submitted_qc>December 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2009</study_first_posted>
  <last_update_submitted>January 13, 2014</last_update_submitted>
  <last_update_submitted_qc>January 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Ambika Ashraf, M.D.</investigator_full_name>
    <investigator_title>Associate Professor, Pediatrics</investigator_title>
  </responsible_party>
  <keyword>insulin sensitivity</keyword>
  <keyword>vascular function</keyword>
  <keyword>flow-mediated dilation</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>ethnicity</keyword>
  <keyword>adolescents</keyword>
  <keyword>females</keyword>
  <keyword>glucose tolerance</keyword>
  <keyword>diabetes</keyword>
  <keyword>hypertension</keyword>
  <keyword>cardiovascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

